Groundbreaking Epilepsy Study to Be Conducted at Dartmouth-Hitchcock Medical Center

Dartmouth-Hitchcock Medical Center (DHMC) will serve as one of the primary clinical sites of a new study of the use of an implanted brain stimulator to improve consciousness during epileptic seizures. Beginning in September, the randomized controlled study will observe temporal lobe epilepsy patients over the course of three years. This study is being led by the Yale School of Medicine, with DHMC and the Mayo Clinic in Rochester, MN, serving as clinical sites.